$AUID
authID Inc. Stock $auid

$auid Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024024363 Filed on March 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$157.4K	$71.90K	$190.0K
YoY Change	315.73%	-72.96%	-63.98%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.062M	$2.170M	$7.882M
YoY Change	-37.05%	-29.85%	-47.09%
% of Gross Profit
Research & Development	$1.205M	$1.134M	$2.800M
YoY Change	8.97%	-28.23%	-55.33%
% of Gross Profit
Depreciation & Amortization	$43.41K	$255.9K	$255.9K
YoY Change	-42.9%	240.87%	-65.88%
% of Gross Profit
Operating Expenses	$3.311M	$3.347M	$10.94M
YoY Change	-25.74%	-29.52%	-52.02%
Operating Profit	-$3.153M		-$10.75M
YoY Change	-28.66%		-51.74%
Interest Expense	$95.78K	-$13.14K	$1.108M
YoY Change	-57.05%	-101.89%	-18.49%
% of Operating Profit
Other Income/Expense, Net	$95.78K	$67.56K	-$8.867M
YoY Change		3897.63%	23723.13%
Pretax Income	-$3.058M	-$3.221M	-$19.62M
YoY Change	-41.43%	-46.43%	-17.12%
Income Tax		-$390.00	$2.864K
% Of Pretax Income
Net Earnings	-$3.058M	-$3.220M	-$19.40M
YoY Change	-41.45%	-46.52%	-19.93%
Net Earnings / Revenue	-1942.82%	-4478.89%	-10210.72%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.32	-$0.38	-$3.15
COMMON SHARES
Basic Shares Outstanding	9.450M shares	7.875M shares	6.154M shares
Diluted Shares Outstanding	9.450M shares		6.154M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.226M	$10.18M	$10.18M
YoY Change	355.06%	214.39%	214.39%
Cash & Equivalents	$7.226M	$10.18M
Short-Term Investments
Other Short-Term Assets	$485.6K	$476.0K	$633.3K
YoY Change	14.25%	-34.74%	-25.3%
Inventory
Prepaid Expenses
Receivables	$328.8K	$91.28K	$91.28K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.251M	$10.90M	$10.90M
YoY Change	286.81%	150.8%	150.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$4.183M	$4.183M
YoY Change	0.0%	0.0%
Intangibles	$283.6K	$327.0K
YoY Change	-42.15%	-42.25%
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$4.467M	$4.510M	$4.510M
YoY Change	-4.9%	-10.29%	-10.29%
TOTAL ASSETS
Total Short-Term Assets	$8.251M	$10.90M	$10.90M
Total Long-Term Assets	$4.467M	$4.510M	$4.510M
Total Assets	$12.72M	$15.41M	$15.41M
YoY Change	86.2%	64.41%	64.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$239.4K	$339.8K	$339.8K
YoY Change	-64.09%	-45.46%	-45.46%
Accrued Expenses	$666.9K	$1.069M	$1.069M
YoY Change	-44.65%	101.37%	101.37%
Deferred Revenue		$131.6K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$228.5K
YoY Change
Total Short-Term Liabilities	$1.526M	$1.665M	$1.665M
YoY Change	-22.28%	33.27%	33.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$224.4K	$224.4K
YoY Change	-100.0%	-97.14%	-97.14%
Other Long-Term Liabilities	$325.0K	$325.0K	$325.0K
YoY Change	0.0%
Total Long-Term Liabilities	$325.0K	$549.4K	$549.4K
YoY Change	-96.29%	-92.99%	-92.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.526M	$1.665M	$1.665M
Total Long-Term Liabilities	$325.0K	$549.4K	$549.4K
Total Liabilities	$1.851M	$2.214M	$2.214M
YoY Change	-82.75%	-75.64%	-75.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$162.6M	-$159.5M
YoY Change	11.87%	13.82%
Common Stock	$173.4M	$172.7M
YoY Change	6704137.65%	23.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.87M	$13.20M	$13.20M
YoY Change
Total Liabilities & Shareholders Equity	$12.72M	$15.41M	$15.41M
YoY Change	86.2%	64.41%	64.41%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.058M	-$3.220M	-$19.40M
YoY Change	-41.45%	-46.52%	-19.93%
Depreciation, Depletion And Amortization	$43.41K	$255.9K	$255.9K
YoY Change	-42.9%	240.87%	-65.88%
Cash From Operating Activities	-$2.948M	-$2.150M	-$8.400M
YoY Change	35.83%	-27.69%	-34.35%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$3.400K
YoY Change		257.89%
Acquisitions
YoY Change
Other Investing Activities		$1.750K	$91.75K
YoY Change			-160.05%
Cash From Investing Activities	$0.00	-$4.850K	$75.15K
YoY Change		-605.21%	-141.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$14.91M
YoY Change			373.89%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		8.515M	$15.38M
YoY Change		-1386.21%	50.36%
NET CHANGE
Cash From Operating Activities	-$2.948M	-2.150M	-$8.400M
Cash From Investing Activities	0.000	-4.850K	$75.15K
Cash From Financing Activities		8.515M	$15.38M
Net Change In Cash	-$2.951M	6.360M	$6.937M
YoY Change	78.97%	-274.99%	-347.92%
FREE CASH FLOW
Cash From Operating Activities	-$2.948M	-$2.150M	-$8.400M
Capital Expenditures	$0.00	-$3.400K
Free Cash Flow	-$2.948M	-$2.147M	-$8.400M
YoY Change	35.83%	-27.78%	-34.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-7.72
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40747
CY2023	dei	Entity Registrant Name EntityRegistrantName	authID Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2069547
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1580 North Logan Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 660, Unit 51767
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80203
CY2023	dei	City Area Code CityAreaCode	516
CY2023	dei	Local Phone Number LocalPhoneNumber	274-8700
CY2023	dei	Security12b Title Security12bTitle	Common Stock par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	AUID
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	40795215	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9450220	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2023	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2023Q4	us-gaap	Cash Cash	10177099	usd
CY2022Q4	us-gaap	Cash Cash	3237106	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91277	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	261809	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	157300	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	476004	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	729342	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	118459	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10901680	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4346716	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	250383	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	327001	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	566259	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4183232	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4183232	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	27595	usd
CY2023Q4	us-gaap	Assets Assets	15411913	usd
CY2022Q4	us-gaap	Assets Assets	9374185	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408965	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1154072	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	131628	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	81318	usd
CY2023Q4	auid	Deferred Contract Liability DeferredContractLiability	124150	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13759	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1664743	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1249149	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	224424	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7841500	usd
CY2023Q4	auid	Deferred Severance DeferredSeverance	325000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2214167	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9090649	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9450220	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9450220	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3179789	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3179789	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	945	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	318	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	172714712	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	140257448	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159530535	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140130159	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12624	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	155929	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13197746	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	283536	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15411913	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9374185	usd
CY2023	us-gaap	Revenues Revenues	190289	usd
CY2022	us-gaap	Revenues Revenues	527415	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7882194	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14676938	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2800373	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6269175	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	255858	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	749900	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1101867	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10938425	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	22797880	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10748136	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-22270465	usd
CY2023	us-gaap	Interest Expense InterestExpense	1108458	usd
CY2022	us-gaap	Interest Expense InterestExpense	1359954	usd
CY2023	us-gaap	Other Income OtherIncome	98230	usd
CY2022	us-gaap	Other Income OtherIncome	-37221	usd
CY2023	auid	Conversion Expense ConversionExpense	7476000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-380741	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8866969	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1397175	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19615105	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23667640	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2864	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7670	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19617969	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-23675310	usd
CY2023	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1524	usd
CY2022	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-366663	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-216069	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	188247	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	217593	usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-554910	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19400376	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24230220	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.19
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-7.72
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.18
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6153881	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3065365	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19400376	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24230220	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-143305	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-55557	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19543681	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24285777	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10895578	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8870168	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3146940	usd
CY2022	auid	Stock Issued During Period Value Common Stock Issued With Convertible Debt StockIssuedDuringPeriodValueCommonStockIssuedWithConvertibleDebt	91757	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	303000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	696393	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	449474	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	66003	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	50000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24230220	usd
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	7992841	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	66003	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	662000	usd
CY2022	auid	Cash Paid For Working Capital Facility CashPaidForWorkingCapitalFacility	300000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-55557	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	283536	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	15332011	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14912904	usd
CY2023	auid	Stock Issued During Period Value Conversion Of Credit Facility Borrowings Into Common Stock StockIssuedDuringPeriodValueConversionOfCreditFacilityBorrowingsIntoCommonStock	900000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	487398	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	438000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	387578	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19400376	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-143305	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13197746	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19400376	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-24230220	usd
CY2023	auid	Conversion Expense ConversionExpense	7476000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	487398	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8870168	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	711269	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	595783	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	438000	usd
CY2023	auid	Shares Issued In Lieu Of Interest SharesIssuedInLieuOfInterest	387578	usd
CY2022	auid	Shares Issued In Lieu Of Interest SharesIssuedInLieuOfInterest	696393	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-380741	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	255858	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	749900	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	150000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-216069	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	188247	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1101867	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-170532	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	234962	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-33150	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-88068	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-167877	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	245932	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-669294	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	50310	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-117689	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	325000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	110064	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	87530	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8372845	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12794400	usd
CY2023	auid	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	91751	usd
CY2022	auid	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	146728	usd
CY2022	us-gaap	Discontinued Operation Amount Of Continuing Cash Flows After Disposal DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal	-299505	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7027	usd
CY2022	auid	Payments To Acquire Property Plant And Equipment From Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentFromDiscontinuedOperations	16159	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16600	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6311	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	75151	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-182274	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14912904	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3146940	usd
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	471816	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1579	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10582	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15384720	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10231623	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-149736	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-53123	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6937290	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2798174	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3237106	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5767276	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	2703	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	270707	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	2703	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10177099	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3237106	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	23345	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	94887	usd
CY2023	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations	364	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2864	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7670	usd
CY2023	auid	Income Taxes Discontinued Operations IncomeTaxesDiscontinuedOperations	1254	usd
CY2022	auid	Income Taxes Discontinued Operations IncomeTaxesDiscontinuedOperations	5627	usd
CY2023	auid	Conversion Of Convertible Notes To Common Stock ConversionOfConvertibleNotesToCommonStock	7856011	usd
CY2022	auid	Conversion Of Convertible Notes To Common Stock ConversionOfConvertibleNotesToCommonStock	50406	usd
CY2023	auid	Conversion Of Credit Facility Borrowings Into Common Stock ConversionOfCreditFacilityBorrowingsIntoCommonStock	900000	usd
CY2022	auid	Cashless Option And Warrant Exercises CashlessOptionAndWarrantExercises	4	usd
CY2022	auid	Settlement Of Accounts Payable With Issuance Of Common Stock SettlementOfAccountsPayableWithIssuanceOfCommonStock	91757	usd
CY2022	auid	Common Stock For Working Capital Facility CommonStockForWorkingCapitalFacility	303000	usd
CY2022	auid	Warrant For Services With The Issuance Of Convertible Debt WarrantForServicesWithTheIssuanceOfConvertibleDebt	449474	usd
CY2023Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	96000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	155000	usd
CY2023Q3	us-gaap	Sale Leaseback Transaction Cumulative Gain Recognized1 SaleLeasebackTransactionCumulativeGainRecognized1	216000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159500000	usd
CY2023	us-gaap	Revenues Revenues	190000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8400000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19600000	usd
CY2023	auid	Non Cash NonCash	11200000	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6
CY2023Q4	auid	Aggregate Gross Proceeds AggregateGrossProceeds	9400000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	8600000	usd
CY2023Q2	auid	Aggregate Gross Proceeds AggregateGrossProceeds	7300000	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	6400000	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	8900000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7900000	usd
CY2023Q2	auid	Aggregate Gross Proceeds AggregateGrossProceeds	900000	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	500000	usd
CY2023Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	929250	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements in conformity with US GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Verified Software License </i>– The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had deferred revenue contract liabilities of approximately $132,000 and $81,000 as of December 31, 2023 and December 31, 2022 respectively for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of December 31, 2023 are expected to be earned over the next twelve months.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Remaining Performance Obligations</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company’s Remaining Performance Obligation (RPO) was $4.03 million, of which $0.13 million is held as deferred revenue and $3.89 million is related to other non-cancelable contracted amounts. The Company estimated the $4.03 million balance based primarily on minimum annual billings associated with signed customer contracts, which have not yet implemented the Company’s software. Based on the contractual terms of the signed customer contracts, we anticipate recognizing this revenue over the next 3 years. However, due to the complexities and estimates inherent in revenue recognition, ultimate revenue recognized may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferred Contract Costs</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the year ended December 31, 2023:</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">Deferred</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Contract Costs</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Carrying Value at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 88%">Additions</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">157,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Carrying Value at December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">157,300</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legacy Authentication Services</i> – The Company historically has sold certain legacy software licenses to customers and revenue is recognized when delivery occurs, and all other revenue recognition criteria have been met. During both 2023 and 2022, the Company provided annual software maintenance support services relating to previously licensed software on a stand-ready basis. These fees were billed in advance and recognized ratably over the requisite service period as revenue.</span></p>
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	132000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	81000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4030000.00	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	130000	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	3890000	usd
CY2023Q4	us-gaap	Investment Owned Balance Contracts InvestmentOwnedBalanceContracts	4030000.00	pure
CY2023	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	157300	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	157300	usd
CY2022Q3	us-gaap	Accounts Receivable Sale AccountsReceivableSale	300000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	150000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk and Major Customers</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that potentially expose the Company to a concentration of credit risk consist of cash and accounts receivable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash: </i>The Company’s cash is deposited at financial institutions and cash balances held in United States (“US”) bank accounts are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At various times during the year, the Company may have exceeded amounts insured by the FDIC. At December 31, 2023, the Company had approximately $9.9 million in funds in the United States which were in excess of the insured amounts by the FDIC. For the Company’s foreign subsidiaries, no amounts are insured. At December 31, 2023, the Company held approximately $700 in cash maintained in a British bank.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023 Revenues and accounts receivable: </i>For the year ended December 31, 2023, 10% of consolidated revenues were derived from International customers and two customers represented 58% of consolidated revenue. As of December 31, 2023, accounts receivable related to three customers amounted to 78% of the accounts receivable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022 Revenues and accounts receivable: </i>For the year ended December 31, 2022, revenue for approximately 70% of the total revenues from continuing operations were derived from two legacy customers. As of December 31, 2022, accounts receivable related to one legacy customer amounted to 86% of the accounts receivable.</span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	auid	Excess Insured Amounts Federal Depository Corporation ExcessInsuredAmountsFederalDepositoryCorporation	9900000	usd
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	700	usd
CY2023	us-gaap	Lease Cost LeaseCost	1500	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1100000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	97000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	220000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2403283	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1770466	shares
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	184492	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	244215	usd
CY2022Q4	auid	Unamortized Working Capital Facility Fees Current UnamortizedWorkingCapitalFacilityFeesCurrent	199156	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	291512	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	135405	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	150566	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	476004	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	729342	usd
CY2022Q4	auid	Unamortized Working Capital Facility Fees Non Current UnamortizedWorkingCapitalFacilityFeesNonCurrent	248945	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1438	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	250383	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	139599	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	139599	usd
CY2023	us-gaap	Depreciation Depreciation	0	usd
CY2022	us-gaap	Depreciation Depreciation	25021	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2379452	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	6311	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-1107867	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	711637	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	566259	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	16600	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	255858	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	327001	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1899276	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1572275	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	327001	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	4640885	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4074626	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	566259	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	173632	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	69331	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	19228	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16461	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16461	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	31888	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	327001	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	339832	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	623130	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	707317	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	145837	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	361816	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	385105	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408965	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1154072	usd
CY2022Q1	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	200000	usd
CY2022Q1	auid	Issued Of Common Stock Origination Fee IssuedOfCommonStockOriginationFee	3562	shares
CY2022Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0975	pure
CY2023Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	7500000	usd
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	59981	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	17836	shares
CY2023	auid	Estimated Grant Date Fair Value EstimatedGrantDateFairValue	449000	usd
CY2023Q4	auid	Percentage Of Convertible Notes Due PercentageOfConvertibleNotesDue	0.0975	pure
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	245000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	9125205	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3256	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	203593	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	17320	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	1080112	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	224424	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7841500	usd
CY2023Q1	auid	Amended Amount AmendedAmount	3600000	usd
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	62.4
CY2023	us-gaap	Management And Service Fees Base Rate ManagementAndServiceFeesBaseRate	1	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	275000	usd
CY2023Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	9.25
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.64
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1200000	usd
CY2022Q1	auid	Unsecured Line Of Credit Facility UnsecuredLineOfCreditFacility	10000000	usd
CY2022Q2	auid	Perfomance Based Bonus Amount PerfomanceBasedBonusAmount	25000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2022Q2	auid	Performance Contributions Aggregate Amount PerformanceContributionsAggregateAmount	240625	usd
CY2022Q2	us-gaap	Insurance Recoveries InsuranceRecoveries	57715	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	24.24
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9450220	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9450220	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3179789	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3179789	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	62816330	shares
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9400000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	8600000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1989676	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	2348347	shares
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	268	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1113904	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.84
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	67488214	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	248169	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.88
CY2022	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P10Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	49712	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.56
CY2022	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeExercised	P8Y9M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20764	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.96
CY2022	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeForfeitedcancelled	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1291597	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.48
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	877250	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.38
CY2023	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P10Y
CY2023	auid	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue	3576759	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	938	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.32
CY2023	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeExercised	P0Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	371166	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.39
CY2023	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeForfeitedcancelled	P6Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1796743	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.2
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3630733	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1073349	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	32.86
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1502214	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1796743	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y6M
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1073349	shares
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19417471	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-25424002	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	12356	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1208777	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-19405115	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-24215225	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0196	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0252	pure
CY2023	auid	Effective Income Tax Rate Loss On Debt Extinguishment EffectiveIncomeTaxRateLossOnDebtExtinguishment	0.0809	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0053	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0303	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0175	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1609	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2157	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0006	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17231979	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14997873	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	7529725	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	7450914	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	676539	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	336475	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1273449	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	963784	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	136961	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	11203	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	33599	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	350418	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	350526	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27232670	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24110775	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	73600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	33400000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14400000	usd
CY2023Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	59200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24100000	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	150000	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	96000	usd
CY2023	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1524	usd
CY2022	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-366663	usd
CY2023	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	8067	usd
CY2022	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	41850	usd
CY2022	auid	Disposal Group Including Discontinued Operation Impairment Of Intangible Assets DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssets	143698	usd
CY2023	auid	Disposal Group Including Discontinued Operation Increase Decrease In Accounts Receivable DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInAccountsReceivable	-105194	usd
CY2022	auid	Disposal Group Including Discontinued Operation Increase Decrease In Accounts Receivable DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInAccountsReceivable	50598	usd
CY2023	auid	Disposal Group Including Discontinued Operation Increase Decrease In Other Current Assets DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInOtherCurrentAssets	-10562	usd
CY2022	auid	Disposal Group Including Discontinued Operation Increase Decrease In Other Current Assets DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInOtherCurrentAssets	-170536	usd
CY2022	auid	Disposal Group Including Discontinued Operation Increase Decrease In Inventory DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInInventory	78806	usd
CY2023	auid	Disposal Group Including Discontinued Operation Increase Decrease In Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInAccountsPayableAndAccruedLiabilities	13759	usd
CY2022	auid	Disposal Group Including Discontinued Operation Increase Decrease In Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInAccountsPayableAndAccruedLiabilities	102486	usd
CY2022	auid	Disposal Group Including Discontinued Operation Increase Decrease In Deferred Revenue DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInDeferredRevenue	36664	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	110064	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	87530	usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	111588	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-279133	usd
CY2021Q4	us-gaap	Lease Cost LeaseCost	2900	usd
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	8000	usd
CY2023	us-gaap	Employee Stock Ownership Plan Esop Plan Description EmployeeStockOwnershipPlanESOPPlanDescription	the Company adopted the new 401(k) plan where employer matches 100% of the employees contribution up to 3% of their salaries and 50% of the employee’s contribution (including both executives and other employees) between 3% and 5% of their salaries.
CY2022	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2500	usd
CY2021	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2500	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P1Y
CY2022Q3	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	1500	usd
CY2023	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	10000	usd
CY2022	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	25000	usd
CY2023	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	2000	usd
CY2022	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	90000	usd
CY2023	dei	Auditor Firm AuditorFirmId	677
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent		usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2022Q4	auid	Deferred Contract Liability DeferredContractLiability		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	auid	Deferred Severance DeferredSeverance		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	auid	Conversion Expense ConversionExpense		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-3.19
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.18
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3065365	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6153881	shares
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	auid	Stock Issued During Period Value Cashless Warrant Exercise StockIssuedDuringPeriodValueCashlessWarrantExercise		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	auid	Conversion Expense ConversionExpense		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities		usd
CY2023	us-gaap	Discontinued Operation Amount Of Continuing Cash Flows After Disposal DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	auid	Payments To Acquire Property Plant And Equipment From Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentFromDiscontinuedOperations		usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023	auid	Cash Paid For Working Capital Facility CashPaidForWorkingCapitalFacility		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations		usd
CY2022	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations		usd
CY2022	auid	Conversion Of Credit Facility Borrowings Into Common Stock ConversionOfCreditFacilityBorrowingsIntoCommonStock		usd
CY2023	auid	Cashless Option And Warrant Exercises CashlessOptionAndWarrantExercises		usd
CY2023	auid	Settlement Of Accounts Payable With Issuance Of Common Stock SettlementOfAccountsPayableWithIssuanceOfCommonStock		usd
CY2023	auid	Common Stock For Working Capital Facility CommonStockForWorkingCapitalFacility		usd
CY2023	auid	Warrant For Services With The Issuance Of Convertible Debt WarrantForServicesWithTheIssuanceOfConvertibleDebt		usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization		usd
CY2023Q4	auid	Unamortized Working Capital Facility Fees Current UnamortizedWorkingCapitalFacilityFeesCurrent		usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets		usd
CY2023Q4	auid	Unamortized Working Capital Facility Fees Non Current UnamortizedWorkingCapitalFacilityFeesNonCurrent		usd
CY2023Q4	us-gaap	Other Assets OtherAssets		usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	auid	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueForfeitedcancelled		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023	auid	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Forfeitedcancelled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueForfeitedcancelled		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	auid	Disposal Group Including Discontinued Operation Impairment Of Intangible Assets DisposalGroupIncludingDiscontinuedOperationImpairmentOfIntangibleAssets		usd
CY2023	auid	Disposal Group Including Discontinued Operation Increase Decrease In Inventory DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInInventory		usd
CY2023	auid	Disposal Group Including Discontinued Operation Increase Decrease In Deferred Revenue DisposalGroupIncludingDiscontinuedOperationIncreaseDecreaseInDeferredRevenue		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001534154

Files In Submission

Name	View Source	Status
0001213900-24-024363-index-headers.html	Edgar Link	pending
0001213900-24-024363-index.html	Edgar Link	pending
0001213900-24-024363.txt	Edgar Link	pending
0001213900-24-024363-xbrl.zip	Edgar Link	pending
auid-20231231.xsd	Edgar Link	pending
ea0201335-10k_authidinc.htm	Edgar Link	pending
ea0201335ex23-1_authidinc.htm	Edgar Link	pending
ea0201335ex31-1_authidinc.htm	Edgar Link	pending
ea0201335ex31-2_authidinc.htm	Edgar Link	pending
ea0201335ex32-1_authidinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
auid-20231231_def.xml	Edgar Link	unprocessable
auid-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0201335-10k_authidinc_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
auid-20231231_cal.xml	Edgar Link	unprocessable
auid-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUID
authID Inc. Stock $auid

2024 Q1 Form 10-K Financial Statement

#000121390024024363 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUID authID Inc. Stock $auid

2024 Q1 Form 10-K Financial Statement

#000121390024024363 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUID
authID Inc. Stock $auid